Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine-primed Tandem CD19/CD20 CAR-T in r/r B-NHL
NCT04697940Phase 2Active, not recruiting
- Start
- Apr 2021
- Primary completion
- May 2025
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of decitabine-primed tandem CAR19/20 engineered T cells in B-cell non-Hodgkin lymphoma (B-NHL). Started Apr 2021; status: active, not recruiting.
02
Drugs
decitabine-primed tandem CAR19/20 engineered T cells
03
Conditions
B-cell non-Hodgkin lymphoma (B-NHL)
Beyond the preview
Go deeper on NCT04697940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04697940.